DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Sundry Debtors | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr | ₹5,028 Cr | ₹3,987 Cr |
What is the latest Sundry Debtors ratio of DR REDDYS LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2023 | ₹7,249 Cr |
Mar2022 | ₹6,676 Cr |
Mar2021 | ₹4,964 Cr |
Mar2020 | ₹5,028 Cr |
Mar2019 | ₹3,987 Cr |
How is Sundry Debtors of DR REDDYS LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2023 | ₹7,249 Cr | 8.57 | |
Mar2022 | ₹6,676 Cr | 34.49 | |
Mar2021 | ₹4,964 Cr | -1.27 | |
Mar2020 | ₹5,028 Cr | 26.11 | |
Mar2019 | ₹3,987 Cr | - |
Compare Sundry Debtors of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹103,501.1 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics | |
MANKIND PHARMA | ₹94,779.2 Cr | -0.4% | 6% | NA | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 5.7% |
2.7% |
29.3% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses